Imaging Technology

AUGUST 29, 2023

Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.

Pharmaceutical 97

Pharmaceutical Radiopharmaceuticals Clinic Medical 97

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Disease Clinic 52

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JULY 5, 2023

Nucleus will use NorthStar’s Ac-225 for their customers’ radioligand pharmaceutical programs. Clinical research and commercial use of Ac-225 have been constrained by chronic short supply due to limitations of current production technology. Ac-225 to Nucleus. NorthStar is positioned to be the first commercial-scale producer of n.c.a.

Medical 92

Medical Radiopharmaceuticals Pharmaceutical Radiation 92

Imaging Technology

AUGUST 28, 2023

The companies will work together to increase near-term production of 225Ac [1] to support ongoing clinical trials and to ensure the large-scale supply of the radioisotope in the long term, addressing growing global demand. Whilst there is high demand, there is a scarcity of 225Ac.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98

Imaging Technology

APRIL 2, 2024

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105